Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
REPLIGEN CORP | Director | Common Stock | 91.1K | $14.5M | $158.85 | Jun 14, 2024 | Direct |
Barinthus Biotherapeutics plc. | Director | Share Option (Right to Buy) | 19.5K | May 10, 2024 | Direct | ||
REPLIGEN CORP | Director | Stock Option (Right to Buy) | 0 | Jun 14, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RGEN | REPLIGEN CORP | Jun 14, 2024 | 0 | $0 | 4/A | Aug 19, 2024 | Director |
RGEN | REPLIGEN CORP | Jun 14, 2024 | 2 | $200K | 4 | Jun 14, 2024 | Director |
RGEN | REPLIGEN CORP | May 16, 2024 | 2 | $0 | 4 | May 20, 2024 | Director |
BRNS | Barinthus Biotherapeutics plc. | May 10, 2024 | 1 | $0 | 4 | May 14, 2024 | Director |
RGEN | REPLIGEN CORP | Feb 27, 2024 | 3 | $1.27K | 4 | Feb 28, 2024 | Director |
RGEN | REPLIGEN CORP | Aug 29, 2023 | 3 | -$11.7K | 4 | Aug 30, 2023 | Director |
RGEN | REPLIGEN CORP | May 18, 2023 | 2 | $0 | 4 | May 22, 2023 | Director |
VACC | Vaccitech plc | May 11, 2023 | 1 | $0 | 4 | May 12, 2023 | Director |
VACC | Vaccitech plc | Dec 31, 2022 | 1 | $0 | 5 | Feb 10, 2023 | Director |
RGEN | REPLIGEN CORP | Sep 9, 2022 | 1 | -$176K | 4 | Sep 9, 2022 | Director |
RGEN | REPLIGEN CORP | May 26, 2022 | 2 | $0 | 4 | May 31, 2022 | Director |
RGEN | REPLIGEN CORP | May 25, 2022 | 5 | -$2.21M | 4 | May 26, 2022 | Director |
RGEN | REPLIGEN CORP | Nov 10, 2021 | 12 | -$1.39M | 4 | Nov 12, 2021 | Director |
RGEN | REPLIGEN CORP | Nov 2, 2021 | 7 | -$729K | 4 | Nov 4, 2021 | Director |
RGEN | REPLIGEN CORP | Sep 14, 2021 | 5 | -$80.6K | 4 | Sep 15, 2021 | Director |
RGEN | REPLIGEN CORP | Sep 1, 2021 | 8 | -$1.12M | 4 | Sep 2, 2021 | Director |
RGEN | REPLIGEN CORP | Aug 17, 2021 | 11 | -$4.8M | 4 | Aug 19, 2021 | Director |
RGEN | REPLIGEN CORP | Jul 20, 2021 | 4 | -$927K | 4 | Jul 22, 2021 | Director |
RGEN | REPLIGEN CORP | Jul 13, 2021 | 6 | -$187K | 4/A | Jul 22, 2021 | Director |
RGEN | REPLIGEN CORP | May 13, 2021 | 2 | $0 | 4 | May 17, 2021 | Director |
RGEN | REPLIGEN CORP | May 11, 2021 | 3 | -$2.1K | 4 | May 13, 2021 | Director |